FDA Expands Labels for Credelio Quattro and Credelio to Include Lyme Disease Prevention and Protection Against Longhorned Ticks
he U.S. Food and Drug Administration (FDA) has approved updated labels for two canine parasiticides, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner).
Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines from the labeling"
Elanco Acquires Former GM Stamping Plant Site to Build Innovation District in Indianapolis
Governor Mike Braun has announced the sale of state-owned land at the former GM Stamping Plant site to Elanco Animal Health for $27 million, marking a major step toward the development of an innovation district in downtown Indianapolis.
Beyond Animal Health: Elanco Fights Food Insecurity for 250 Families
Just a mile away from Elanco Animal Health’s soon-to-open headquarters, families in the area struggle to keep food on the table. To help, Elanco has launched a new initiative — Nutrition Secure Indy — designed to feed 250 local families for an entire year while studying how access to quality food impacts communities.
New Elanco Report Reveals Scope of Dog Itch Epidemic—and Urges Cost-Effective Solutions
A newly released report by Elanco Animal Health sheds light on an increasingly common issue in pet care: canine itch. According to the data, nearly 9 out of 10 dog owners in the U.S. report that their pet has experienced itchiness in the past year, with seasonal allergies and environmental triggers like pollen playing a major role in flare-ups.
Elanco Animal Health Expands Kansas Facility to Meet Rising Global Demand
Elanco Animal Health is set to significantly enhance its production capabilities with the expansion of its Kansas manufacturing facility. This strategic investment is part of Elanco’s broader initiative to bolster its supply chain and accommodate the growing global demand for its animal health products. The Kansas facility, a key component of Elanco’s production network, will receive substantial infrastructure upgrades aimed at increasing production efficiency and capacity.